Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 20, 2019
Reporting Period: The filing discloses a corporate presentation current as of March 20, 2019, intended for use at industry conferences.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of a corporate presentation (Exhibit 99.1) and does not contain a financial statement or tabular data within the body of the document.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document is a procedural disclosure under Regulation FD regarding the distribution of summary business information.
Guidance, Outlook, and Risks
- Management Commentary: The Company provides summary business information via a "Corporate Presentation" attached as Exhibit 99.1.
- Forward-Looking Statements: The Company explicitly disclaims any obligation to correct or update the material in the Corporate Presentation in the future.
- Legal Status: The information in this Form 8-K and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for actual financial data and strategic outlook, as the 8-K text itself contains no numbers.
- Verify the date of the presentation (March 20, 2019) to ensure data currency, noting the Company's disclaimer regarding future updates.
- Confirm that the presentation is not incorporated by reference into other filings unless expressly stated.